or Try an Advanced Search...

    Respiratory Diseases Stocks List

    Symbol Grade Name % Change
    WINT F Windtree Therapeutics, Inc. 13.33
    TBPH D Theravance Biopharma, Inc. 4.69
    MRK C Merck & Company, Inc. 2.36
    VMD F Viemed Healthcare, Inc. 2.09
    REVB F Revelation Biosciences, Inc. 1.36
    SVRA D Savara, Inc. 1.04
    SMLR F Semler Scientific, Inc. 0.57
    VRNA F Verona Pharma plc 0.22
    SPRY D ARS Pharmaceuticals, Inc. 0.11
    ALVO D Alvotech 0.00
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Appliances & Equipment Medical Care Facilities Medical Devices
    Related Stock Lists: Medicine Cystic Fibrosis Hypertension Respiratory Therapy Angina Antibiotics Asthma Biopharmaceutical Cancer Chronic Condition Chronic Obstructive Pulmonary Disease Coronavirus Diabetes Disease Heart Failure Infection Inflammation Life Sciences Medication Nasdaq 100

    Related ETFs - A few ETFs which own one or more of the above listed Respiratory Diseases stocks.

    Symbol Grade Name Weight
    IBBQ B Invesco Nasdaq Biotechnology ETF 12.46
    PPH A Market Vectors Pharmaceutical ETF 12.2
    MEDX D Horizon Kinetics Medical ETF 10.95
    FTXH C First Trust Nasdaq Pharmaceuticals ETF 10.89
    PJP A PowerShares Dynamic Pharmaceuticals 9.12
    View all Respiratory Diseases ETFs...
    Compare ETFs
    Compare FTXH to PJP Compare IBBQ to PPH Compare MEDX to PJP

        Respiratory Diseases Stocks Recent News

        Date Stock Title
        Feb 7 VMD (Exclusive) Stocks To Watch, PRO+ Edition
        May 15 MRK Merck to Present New Data at 2024 ASCO Annual Meeting Demonstrating Advancements in Novel Oncology Treatment Approaches Across Broad Portfolio and Diverse Pipeline
        May 14 TBPH Theravance (TBPH) Q1 Earnings Top, Revenues Match Estimates
        May 14 MRK Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility
        May 14 MRK Merck cancels trial of melanoma treatment due to immune-mediated adverse events
        May 13 TBPH Theravance Biopharma, Inc. (TBPH) Q1 2024 Earnings Call Transcript
        May 13 TBPH Theravance Biopharma (TBPH) Reports Q1 Loss, Misses Revenue Estimates
        May 13 TBPH Theravance Biopharma GAAP EPS of -$0.24 beats by $0.01, revenue of $14.51M beats by $0.56M
        May 13 TBPH Theravance Biopharma, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
        May 13 MRK Merck Halts Skin Cancer Drug Trial On High Discontinuation Rate - A Setback in High-Risk Melanoma Treatment
        May 13 REVB REVB: In Great Position For Testing
        May 13 MRK Merck discontinues testing of experimental skin cancer combo therapy
        May 13 MRK Merck Provides Update on Phase 3 KeyVibe-010 Trial Evaluating an Investigational Coformulation of Vibostolimab and Pembrolizumab as Adjuvant Treatment for Patients With Resected High-Risk Melanoma
        May 13 SPRY ARS Pharmaceuticals Inc (SPRY) Q1 2024 Earnings: Aligns with EPS Projections Amidst Regulatory ...
        May 12 TBPH Theravance Biopharma Q1 2024 Earnings Preview
        May 11 SPRY ARS Pharmaceuticals First Quarter 2024 Earnings: US$0.11 loss per share (vs US$0.16 loss in 1Q 2023)
        May 10 REVB Revelation Biosciences GAAP EPS of -$2.46
        May 10 REVB Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2024
        May 10 VRNA Verona Pharma PLC Reports Q1 2024 Earnings: A Detailed Financial and Strategic Overview
        May 10 VRNA Verona Pharma plc (NASDAQ:VRNA) Q1 2024 Earnings Call Transcript
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Appliances & Equipment Medical Care Facilities Medical Devices
        Related Stock Lists: Medicine Cystic Fibrosis Hypertension Respiratory Therapy Angina Antibiotics Asthma Biopharmaceutical Cancer Chronic Condition Chronic Obstructive Pulmonary Disease Coronavirus Diabetes Disease Heart Failure Infection Inflammation Life Sciences Medication Nasdaq 100
        Respiratory Diseases

        Respiratory diseases are a group of conditions that affect the lungs and airways. These diseases can range from mild to severe and can include asthma, COPD, pneumonia, and lung cancer. Symptoms of respiratory diseases can include difficulty breathing, coughing, wheezing, and chest pain. Treatment for respiratory diseases can include medications, lifestyle changes, and surgery.

        Browse All Tags